McKesson Corporation (MCK) Stock

McKesson Corporation trades at a P/E ratio of 27.48, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 18.28 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 1.10 indicates reasonable value when growth is considered.

With a beta of 0.50, McKesson Corporation is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 5.04 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

McKesson Corporation achieves a profit margin of 0.84%, meaning it retains $0.84 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 1.29% reveals how efficiently the company runs its core business operations before interest and taxes.0

McKesson Corporation's revenue grew by 23.40% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends. Earnings decreased by 10.70% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES industry averages for proper context.

McKesson Corporation offers a dividend yield of 0.42%, paying $2.84 per share annually. This modest yield below 2% suggests the company prioritizes growth investments over current income. While the dividend provides some return, investors are likely attracted more by capital appreciation potential than income generation. To receive the next dividend, shares must be purchased before the ex-dividend date of 9/2/2025.

The dividend sustainability can be assessed through the payout ratio - McKesson Corporation pays $2.84 per share in dividends against earnings of $24.99 per share, resulting in a payout ratio of 11.36%. This conservative payout below 30% indicates excellent dividend safety with substantial room for future increases. The company retains most earnings for growth while still rewarding shareholders. The next dividend payment is scheduled for 10/1/2025.

McKesson Corporation has a market capitalization of $85.41B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 124.38M shares outstanding, the company's ownership is relatively concentrated. As a participant in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES industry, it competes with other firms in this sector.

McKesson Corporation's book value per share is -$15.74, while the current stock price is $710.95, resulting in a price-to-book (P/B) ratio of -45.17. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

16 analysts cover MCK with 75% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $788.57 implies 10.9% upside, but targets are often adjusted to follow price moves rather than predict them.

Current analyst recommendations:2 Strong Buy, 10 Buy, 3 Hold, 01 Strong Sell. The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

RSI data is not available for this stock.

MACD and moving average data are not available for this stock.